BC

Bennett G. Childs

BA Buck Institute For Research On Aging: 9 patents #13 of 45Top 30%
MF Mayo Foundation: 9 patents #94 of 1,749Top 6%
UB Unity Biotechnology: 9 patents #11 of 35Top 35%
📍 Rochester, MN: #612 of 3,042 inventorsTop 25%
🗺 Minnesota: #8,331 of 52,454 inventorsTop 20%
Overall (All Time): #535,568 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12285427 Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor Remi-Martin Laberge, Judith Campisi, Marco Demaria, Jan M.A. van Deursen, Nathaniel David +1 more 2025-04-29
11963957 Treating cardiovascular disease by selectively eliminating senescent cells Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Nathaniel David +2 more 2024-04-23
10517866 Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor Remi-Martin Laberge, James L. Kirkland, Tamar Tchkonia, Yi Zhu, Nathaniel David +3 more 2019-12-31
10478432 Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more 2019-11-19
10478433 Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Darren J. Baker +5 more 2019-11-19
10413542 Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase Remi-Martin Laberge, Nathaniel David, Alain P. Vasserot, Darren J. Baker, James L. Kirkland +3 more 2019-09-17
10328073 Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more 2019-06-25
10328058 Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques Darren J. Baker, Marco Demaria, Albert Davalos, Jan M.A. van Deursen, James L. Kirkland +5 more 2019-06-25
10010546 Treatment of ophthalmic conditions by selectively removing senescent cells from the eye Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more 2018-07-03